How many people are attending Women’s Health Innovation Symposium: From Evidence to Investment?

165 people have registered so far out of 165 available spots.

How do I register for Women’s Health Innovation Symposium: From Evidence to Investment?

You can register for Women’s Health Innovation Symposium: From Evidence to Investment through the original event page on Luma. Click the "View on Luma" button above, or save it to your Rifio account to get reminders.

Women’s Health Innovation Symposium: From Evidence to Investment

Name: Women’s Health Innovation Symposium: From Evidence to Investment
Start: 2026-10-28T17:30:00+00:00
End: 2026-10-28T19:30:00+00:00
Location: ETH HG, Rämistrasse 101, 8006 Zürich, Switzerland

About this event

Despite rapid advancements in modern medicine, severe clinical data gaps and investment bottlenecks continue to hinder female-centric healthcare. Hosted by Nucleate Switzerland, this premier symposium is designed to break down traditional industry silos by convening a curated ecosystem of venture capitalists, entrepreneurs, clinical operators, and pharmaceutical executives. Together, we will explore actionable strategies to mobilize capital, leverage real-world evidence, and drive systemic change in gender-sensitive medicine.

Join us for an evening of high-impact dialogue featuring some of the most prominent voices in the European healthcare sector. The summit will anchor on a keynote address from Reinhart Capital, followed by two core panels tackling the clinical evidence gap and the frontier of technological venture creation in women's health. Whether you are an investor scaling the next breakthrough, a clinician navigating off-label data, or an entrepreneur building the future of diagnostics, this event offers an unparalleled opportunity to forge the strategic partnerships needed to redefine the standard of care.

This program is proudly sponsored by Blooridge and is supported by Health Science Club.

Agenda

18:30 - 18:35 Nucleate Switzerland Welcome and Introduction

18:35 - 18:50 Keynote: Nina Portier Reinhart, Managing Director & Co-Founder, Reinhart Capital

18:50 - 19:30 Panel One: The Clinical Evidence Gap in Women’s Health

Moderator: Tina Tianlan Cai, Nucleate Switzerland

Leyla Hernandez Donoso: Real-World Evidence (RWE) Expert, Novo Nordisk
Dr. Martin Kiebler: Physician, Obstetrics & Gynecology
Elisabeth Mostofi: Partner, Capys Consulting GmbH | Commercialization Executive with 25+ Years in Global Pharma
Laura Titaro: Co-Founder, Blooridge | Expert in Patient Advocacy and Insurance

19:30 - 19:35 Spotlight Presentation: Nicole Estermann, Managing Director, Artemis Women’s Health Foundation

19:35 - 19:45 Break

19:45 - 20:25 Panel Two: Venture Creation & Technological Innovation in Women’s Health

Moderator: Lan Zuo Gillet, Founder, Tech4Eva

Cinzia Donato: PhD, COO & CSO, Hera Biotech
Lisa Falco: Co-Founder & CEO, N23 Health (Pioneering accessible breast cancer detection) | Forbes Contributor
Alexandra Hirzel: Founder & Investor, The Scale Foundry
Sanjana Rao: Co-Founder, Miyara (AI powered menopause Companion app)

20:25 - 20:30 Special Announcement: New Initiative Introduction

20:30 - 21:30 Networking Apéro

Create a free account to see descriptions, save events, and more

About Women’s Health Innovation Symposium: From Evidence to Investment in Zürich

Women’s Health Innovation Symposium: From Evidence to Investment is a free independent taking place on Wednesday, October 28, 2026 at ETH HG, Rämistrasse 101, 8006 Zürich, Switzerland, Zürich, Switzerland. This independent is organised by Nucleate Global Events Calendar. Attendance is free — register to secure your spot. Currently 165 people have registered out of 165 spots. The event runs for approximately 2 hours.